Heimdall Insights

Global Naltrexone Buprenorphine Market

Sizing, Segmentation, & Growth Forecast (2025-2030)

Last updated: July 2026

Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.

Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).

1. Summary

The Global Naltrexone Buprenorphine Market was valued at $4.8 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 10.2% CAGR, to an estimated market size of $7.7 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The global naltrexone and buprenorphine market includes pharmaceutical products used in Medication-Assisted Treatment (MAT) for substance use disorders, primarily Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD). The scope covers various formulations including oral, sublingual, long-acting injectables, and implants, while excluding non-pharmacological therapies and traditional abstinence-only programs.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Naltrexone Buprenorphine Market in the period 2025-30:

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:

Geographies

  • North America
  • Europe
  • Asia-Pacific
  • Rest of World

Segments

  • Buprenorphine-based Products
  • Naltrexone-based Products